We are live on ! Find out more
VIVS icon

VivoSim Labs

42 hedge funds and large institutions have $3.43M invested in VivoSim Labs in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 2

29% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 7

14% more funds holding

Funds holding: 37 → 42 (+5)

0.24% less ownership

Funds ownership: 23.27% → 23.03% (-0.24%)

32% less capital inflows, than outflows

Capital inflows: $115K | Capital outflows: $170K

Holders
42
Holders Change
+5
Holders Change %
+13.51%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
7
Closed
2
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
-$17K

VIVS Hedge Fund Activity: Q2 2022 in Review

42 of the 5,963 institutional investors tracked by Wall St. Rank reported a position in VivoSim Labs (VIVS) for Q2 2022, worth a combined $3.43M — down 54% from $7.42M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new VIVS positions and 2 closed out — a net gain of 5 holders — while 9 added to existing stakes and 7 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $53.6K. The largest seller was BlackRock, cutting an estimated $50.1K.

  • 42 institutional investors held VivoSim Labs (VIVS) as of Q2 2022, up from 37 in Q1 2022.
  • Funds reported $3.43M of VivoSim Labs stock for Q2 2022, down 54% quarter-over-quarter.
  • 7 funds opened new VivoSim Labs positions in Q2 2022 and 2 closed out, a net change of +5 holders.
  • The largest VivoSim Labs buyer in Q2 2022 was Susquehanna International Group, an estimated $53.6K added.
  • The largest VivoSim Labs seller in Q2 2022 was BlackRock, an estimated $50.1K sold.

Based on aggregated 13F filings for Q2 2022.